<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03214705</url>
  </required_header>
  <id_info>
    <org_study_id>CTP predicts DCI</org_study_id>
    <nct_id>NCT03214705</nct_id>
  </id_info>
  <brief_title>Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage</brief_title>
  <official_title>Role of Computed Tomography Perfusion in Detection of Patients at Risk for Delayed Cerebral Ischemia After Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective evaluation of patients with subarachnoid hemorrhage (SAH) will be done by
      computed tomography angiography (CTA) and perfusion imaging (CTP) for any correlation between
      degree of vasospasm and perfusion deficit as well as evaluating the ability of CTP to predict
      delayed cerebral ischemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebral vasospasm is a serious complication of subarachnoid haemorrhage . In the first 2
      weeks of SAH, angiographic vasospasm is seen up to 40-70% of patients and causes ischemic
      deficits in 15-36% of patients.

      The best clinical indicator of significantly reduced brain perfusion (cerebral blood flow
      (CBF)&lt;20 ml per 100 g/min) is the presence of new neurologic deficits. However, clinical
      symptoms may be vague and mimic other conditions in patients with SAH.

      CT Perfusion can be used in the evaluation of patients with possible vasospasm after
      subarachnoid hemorrhage (SAH). It can thus be used to assess cerebral ischemia and infarction
      as a result of vasospasm after SAH.

      The presence of cerebral vasospasm identified with transcranial Doppler, digital subtraction
      angiography, or CT angiography (CTA) is frequently used to confirm DCI. Presence of
      vasospasm, however, does not prove the presence of ischemia and absence of vasospasm does not
      rule out. Better diagnostic tests in the acute stage of deterioration, possibly caused by
      DCI, are therefore needed. In patients with SAH, CTP has recently been shown to be promising
      for detection of early ischemia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Anticipated">March 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>21 Days</target_duration>
  <primary_outcome>
    <measure>Cerebral blood flow (CBF) on Admission</measure>
    <time_frame>3 days from the attack</time_frame>
    <description>Cerebral blood flow (CBF) on Admission in units of ml/100 gram brain tissue/ minute.
The measurements will be compared with the outcome of the patient (namely monitoring delayed cerebral ischemia in SAH patients) to test if early CT perfusion could predict the poor outcome in SAH patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral blood volume (CBV) on Admission</measure>
    <time_frame>3 days from the attack</time_frame>
    <description>Cerebral blood volume (CBF) on Admission in units of ml/100 gram brain tissue.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean transit time (MTT) on Admission</measure>
    <time_frame>3 days from the attack</time_frame>
    <description>Mean transit time (MTT) on Admission in units of seconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of vasospasm to perfusion abnormality using Comparing between CT angiography and CT perfusion in patients with subarachnoid hemorrhage</measure>
    <time_frame>4-14 days from the attack</time_frame>
    <description>Evaluating results of CT angiography and CT perfusion in patients for Correlating vasospasm and perfusion abnormality. Results will be dichotomous; positive and negative, then tested by cross tabulation.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Cerebral Vasospasm</condition>
  <condition>Delayed Cerebral Ischemia</condition>
  <arm_group>
    <arm_group_label>Patients with poor outcome</arm_group_label>
    <description>Follow up of patients is done for 21 days by combined clinical and radiological examination. Poor clinical outcome is associated with vasospasm leading to permanent neurological deficit, stroke or death.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without poor outcome</arm_group_label>
    <description>Patients who do not develop delayed cerebral ischemia or stroke, confirmed by combined clinical and radiological examination.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having subarachnoid hemorrhage whether post aneurysmal or spontaneous
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients presented with subarachnoid haemorrhage

        Exclusion Criteria:

          -  Patients with abnormal renal functions with creatinine ≥ 2 mg/dl/

          -  Patients with hypersensitivity to contrast media.

          -  Contraindication to radiation as pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Abdel-Tawab</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Afaf A. Hasan, Profosser</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed A. Ahmed, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hany M. Seif, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hazem A. Youssef, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Assiut unviersity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Abdel-Tawab</last_name>
    <phone>+201009319309</phone>
    <email>dr.m.tawab@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mohamed Abdel-Tawab Mohamed</name>
      <address>
        <city>Assiut</city>
        <zip>71511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Abdel-Tawab</last_name>
      <phone>+201009319309</phone>
      <email>dr.m.tawab@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Aralasmak A, Akyuz M, Ozkaynak C, Sindel T, Tuncer R. CT angiography and perfusion imaging in patients with subarachnoid hemorrhage: correlation of vasospasm to perfusion abnormality. Neuroradiology. 2009 Feb;51(2):85-93. doi: 10.1007/s00234-008-0466-7. Epub 2008 Oct 11.</citation>
    <PMID>18850093</PMID>
  </reference>
  <reference>
    <citation>Binaghi S, Colleoni ML, Maeder P, Uské A, Regli L, Dehdashti AR, Schnyder P, Meuli R. CT angiography and perfusion CT in cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2007 Apr;28(4):750-8.</citation>
    <PMID>17416833</PMID>
  </reference>
  <reference>
    <citation>Dankbaar JW, de Rooij NK, Rijsdijk M, Velthuis BK, Frijns CJ, Rinkel GJ, van der Schaaf IC. Diagnostic threshold values of cerebral perfusion measured with computed tomography for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 2010 Sep;41(9):1927-32. doi: 10.1161/STROKEAHA.109.574392. Epub 2010 Aug 5.</citation>
    <PMID>20689085</PMID>
  </reference>
  <reference>
    <citation>Muñoz-Guillén NM, León-López R, Túnez-Fiñana I, Cano-Sánchez A. From vasospasm to early brain injury: new frontiers in subarachnoid haemorrhage research. Neurologia. 2013 Jun;28(5):309-16. doi: 10.1016/j.nrl.2011.10.015. Epub 2012 Jan 21. Review. English, Spanish.</citation>
    <PMID>22264777</PMID>
  </reference>
  <reference>
    <citation>Wintermark M, Sincic R, Sridhar D, Chien JD. Cerebral perfusion CT: technique and clinical applications. J Neuroradiol. 2008 Dec;35(5):253-60. doi: 10.1016/j.neurad.2008.03.005. Epub 2008 May 7. Review.</citation>
    <PMID>18466974</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2017</study_first_submitted>
  <study_first_submitted_qc>July 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>August 20, 2017</last_update_submitted>
  <last_update_submitted_qc>August 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed Abdel-Tawab Mohamed</investigator_full_name>
    <investigator_title>Assistant Lecturer</investigator_title>
  </responsible_party>
  <keyword>CT perfusion</keyword>
  <keyword>Subarachnoid hemorrhage</keyword>
  <keyword>Vasospasm</keyword>
  <keyword>Delayed cerebral ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Vasospasm, Intracranial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

